Development and validation of a specific method for the detection and quantification of Bortezomib in the prepared Bortezomib bovine serum albumin nanoparticles
DOI:
https://doi.org/10.31351/vol35iss3pp151-158Keywords:
Albumin nanoparticles, Bortezomib, HPLC, validation, Iraq.Abstract
New, simple and precise analytical method for the detection of Bortezomib which it is a selecti proteosome inhibitor acting as powerful anticancer drug. This method is developed and validated using reverse phase High performance liquid chromatography (HPLC) device with( C18,4.6×250mm )column, mobile phase composed of methanol: water (70:30) , isocratic flow rate of 1 ml/min and UV detection at 270 nm. The retention time for this drug is found to be 6.77 minute by utilizing this method. It is also proved to be precise and specific with an RSD% less than 2% which complies with the requirement of ICH. It also shows a linearity in the both responses (area and height) in the range of 10-100 µg/ml with a R2 0.997 and 0.998 respectively, indicating a wide range for the Bortezomib measurement in different pharmaceutical formulations. LOD and LOQ were also calculated to be 3.2 and 9.6 µg/ml respectively, showing a low level for detection and quantification of the item. The accuracy also is determined to be 99.83%±0.77. In conclusion the suggested method is validated according to ICH guidelines regarding precision, specificity, linearity, accuracy and robustness.
How to Cite
Publication Dates
Received
Revised
Accepted
Published Online First
References
Kozalak G, Bütün İ, Toyran E, Koşar A. Review on Bortezomib Resistance in Multiple Myeloma and Potential Role of Emerging Technologies. Pharmaceuticals. 2023;16(1).
Najana SB, Bollikolla HB. Determination of enantiomer impurity in Bortezomib to injection formulation by using normal-phase liquid chromatography. Futur J Pharm Sci. 2021;7(1).
Elzoghby AO, Samy WM, Elgindy NA. Albumin-based nanoparticles as potential controlled release drug delivery systems. J Control Release. 2012;157:168–82.
Clemens J, Longo M, Seckinger A, Hose D, Haefeli WE, Weiss J, et al. Stability of the proteasome inhibitor bortezomib in cell-based assays determined by UHPLC-MS/MS. J Chromatogr A. 2014;1345:128–38.
Kamalzadeh Z, Babanezhad E, Ghaffari S, et al. Determination of Bortezomib in API Samples Using HPLC. J Chromatogr Sci. 2017;55(7):697–705.
Byrn SR, Tishmack PA, Milton MJ, van de Velde H. Analysis of two commercially available bortezomib products. AAPS PharmSciTech. 2011;12(2):461–7.
Srinivasulu K, Naidu MN, Rajasekhar K, et al. Stability Indicating LC Method for Bortezomib. Chromatogr Res Int. 2012;2012:801720.
Rao JK, Mohan B, Venugopal N, et al. Stability-indicating HPLC method for Bortezomib. Int J Pharm Chem Anal. 2016;3(3):150.
Jagdale AS, Pendbhaje NS, Nirmal RV, et al. RP-HPLC estimation of brexpiprazole using QbD. Futur J Pharm Sci. 2021;7(1).
Hasan HJ, Ghareeb MM. Spectrophotometric estimation of vincristine sulfate and BSA. Pharmacia. 2024;71:1–9.
Neamah Al-Shaibani AJ, Ghareeb MM. Formulation, in vitro and in vivo evaluation of olanzapine nanoparticles dissolving microneedles for transdermal delivery. Pharmacia. 2024;71:1–13.
ICH C. ICH Topic Q 1 A (R2) stability testing of new drug substances and products. European Medicines Agency. 2003.
Shah S, Famta P, Sharma A, Kumar R, Pandey G, et al. Quality by design empowered preparation of itraconazole albumin nanoparticles for prostate cancer. Drug Deliv Transl Res. 2025;15(1):253–68.
Ghosh A, Woolum K, Knopp MV, Kumar K. Validation of a reversed-phase high-performance liquid chromatography (RP-HPLC) method for analysis of [11C]Nicotine. J Radioanal Nucl Chem. 2020;326(3):1719–25.
Al-phalahy BA, Mohammed MJ. Exploration of the separation mechanism of flurbiprofen and nimesulide utilizing RP-HPLC. Baghdad Sci J. 2024.
Marques-Marinho FD, Freitas BD, Zanon JC, Reis IA, Lima AA, Vianna-Soares CD. Development and validation of a RP-HPLC method for simvastatin capsules. Curr Pharm Anal. 2013;9(1):2–12.
Al-Saqqa AM, Hasian JA, Al-Laham AM. Simultaneous determination of piroxicam and codeine phosphate hemihydrate in a pharmaceutical dosage form using validated HPLC method. Baghdad Sci J. 2023;20(3):681–9.
Kako D, Ghareeb MM, Al-Lami MS. High-performance liquid chromatography (HPLC) method validation for identifying and quantifying rebamipide in ethosomes. Cureus. 2024.
Wenzl T, Haedrich J, Schaechtele A, Robouch P, Stroka J. Guidance document on the estimation of LOD and LOQ for measurements in the field of contaminants in feed and food. 2016.
Patel KY, Dedania ZR, Dedania RR, Patel U. QbD approach to HPLC method development and validation of ceftriaxone sodium. Futur J Pharm Sci. 2021;7(1).
Bhardwaj SK. A review: HPLC method development and validation. Int J Anal Bioanal Chem. 2015;5(4):76–81.
Al-Shami N, Naseef H, Moqadi R, Kanaze F. HPLC method development and validation for the determination of apixaban and clopidogrel in novel fixed-dose combination tablets. J Chem. 2024.
Elias KG, Hilal Y. Development and validation of a simple and sensitive reverse-phase high performance liquid chromatographic method for the determination of ibuprofen in pharmaceutical suspensions. Baghdad Sci J. 2023;20(2):550–9.
Srinubabu G, Raju CAI, Sarath N, Kumar PK, Rao JVLNS. Development and validation of a HPLC method for the determination of voriconazole in pharmaceutical formulation using an experimental design. Talanta. 2007;71(3):1424–9.
Taşkın D. Development and validation of a rapid HPLC-DAD method for determination of favipiravir in pharmaceutical formulation. Clin Exp Health Sci. 2021;12(3):648–52.
Ahmed SS, Rasheed AS. RP-HPLC method for simultaneously quantifying the antiviral drug contents of acyclovir, amantadine, and oseltamivir in pharmaceutical formulations. Iraqi J Sci. 2024;65(3):1188–99.
Prajapati SK, Jain A, Bajpai M. Development and validation of the RP-HPLC method for quantification of tavaborole. Anal Methods. 2024;16(30):5280–7.
Demurtas A, Pescina S, Nicoli S, Santi P, de Araujo DR, Padula C. Validation of a HPLC-UV method for the quantification of budesonide in skin layers. J Chromatogr B. 2021;1164:122512.
Downloads
Published
License
Copyright (c) 2026 Iraqi Journal of Pharmaceutical Sciences
This work is licensed under a Creative Commons Attribution 4.0 International License.
